Commission Implementing Regulation (EU) 2016/549 of 8 April 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances bentazone, cyhalofop butyl, diquat, famoxadone, flumioxazine, DPX KE 459 (flupyrsulfuron-methyl), metalaxyl-M, picolinafen, prosulfuron, pymetrozine, thiabendazole and thifensulfuron-methyl
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
236/2016 In force in the EEA
Yes Legal documents
Commission Implementing Regulation (EU) 2016/549 of 8 April 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances bentazone, cyhalofop butyl, diquat, famoxadone, flumioxazine, DPX KE 459 (flupyrsulfuron-methyl), metalaxyl-M, picolinafen, prosulfuron, pymetrozine, thiabendazole and thifensulfuron-methyl
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2016/549 frá 8. apríl 2016 um breytingu á framkvæmdarreglugerð (ESB) nr. 540/2011 að því er varðar framlengingu á samþykkistímabilum fyrir virku efnin bentasón, sýhalófopbútýl, díkvat, famoxadón, flúmíoxasín, DPX KE 459 (flúpýrsúlfúrón-metýl), metalaxýl-M, píkólínafen, prósúlfúrón, pýmetrósín, þíabendasól og þífensúlfúrónmetýl
Durchführungsverordnung (EU) 2016/549 der Kommission vom 8. April 2016 zur Änderung der Durchführungsverordnung (EU) Nr. 540/2011 hinsichtlich der Verlängerung der Laufzeit der Genehmigung für die Wirkstoffe Bentazon, Cyhalofopbutyl, Diquat, Famoxadon, Flumioxazin, DPX KE 459 (Flupyrsulfuron-methyl), Metalaxyl-M, Picolinafen, Prosulfuron, Pymetrozin, Thiabendazol und Thifensulfuron-methyl
Kommisjonens gjennomføringsforordning (EU) 2016/549 av 8. april 2016 om endring av gjennomføringsforordning (EU) nr. 540/2011 med hensyn til forlengelse av godkjenningsperioden for de aktive stoffene bentazon, cyhalofop-butyl, dikvat, famoksadon, flumioksazin, DPX KE 459 (flupyrsulfuron-metyl), metalaksyl-M, pikolinafen, prosulfuron, pymetrozin, tiabendazol og tifensulfuron-metyl
History
03.12.2016
Adopted JCD confirmed entry into force date
03.12.2016
Compliance date in the EEA
02.12.2016
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
17.10.2016
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
08.04.2016
Adoption date in the EU
29.04.2016
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.